Newsroom
This page contains up-to-date information on the global intellectual property proceedings relating to CRISPR-Cas9 gene editing, as well as relevant press coverage and answers to frequently asked questions.
US Legal Events
U.S. Patent and Trademark Office issued U.S. Patent No. 10,266,850 (‘the ‘850 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier
April 23, 2019
U.S. patent office issued third CRISPR patent to CVC; indicates it will issue a fourth
March 12, 2019
U.S. patent office indicates it will issue third CRISPR patent to UC
February 8, 2019
FAQ
We answer some commonly asked questions on the CRISPR-Cas9 intellectual property situation globally.
Learn more
International Patent Landscape
European Patent Office (EPO) awarded the Doudna-Charpentier team a broad CRISPR-Cas9 patent (EP Patent No. 3 401 400)
April 3, 2019
“Europe: Legal issues lead to invalidation of second Broad patent; significant reduction in scope of third Broad patent”
February 15, 2019
Europe: Doudna-Charpentier team awarded European patents
March 9, 2018
